Alkermes plc (ALKS) Reports Second Quarter Fiscal 2012 Financial Results  
11/3/2011 8:07:03 AM

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for its second quarter of fiscal 2012, which ended on Sept. 30, 2011. These are the first financial results released by Alkermes plc (Alkermes) following the successful completion on Sept. 16, 2011, of the merger of Alkermes, Inc. with Elan Drug Technologies (EDT). Alkermes is a new, growing, global leader in central nervous system (CNS) therapeutics, characterized by its broad portfolio of commercial products and robust pipeline of new product candidates.